Press Release Details

Special Event Highlights BioHorizons' Legacy, Current Successes, and Vision

BIRMINGHAM, Ala. — July 22, 2024 — BioHorizons, one of the world’s largest dental implant companies and a subsidiary of Henry Schein, Inc. (Nasdaq: HSIC), recently celebrated its 30th anniversary. At an event at its Birmingham headquarters, the Company reflected on its remarkable growth from humble beginnings in 1994 to its current position as a leader in the dental implant industry that employs more than 700 team members worldwide.

The onsite and virtual celebration, themed “Past, Present, and Inspiring for the Future,” featured BioHorizons' Executive Vice President and COO, Todd Strong, reflecting on the Company's rich history; BioHorizons' President and CEO, Steve Boggan, discussing  the Company's current achievements and exciting future vision; and Emmy award-winning speaker Timothy Alexander, known for his popular TED Talk, who shared an inspiring vision for overcoming adversity.  

“In celebration of BioHorizons’ 30th anniversary, we reflect on our unwavering dedication to science, innovation, and service, as well as our rich legacy of groundbreaking dental implant designs and tissue regeneration products,” said Mr. Boggan. “We are incredibly grateful to our team members for their unwavering commitment to our mission. Our roots in the Birmingham community have been integral to our success, and we look forward to continuing to advance dental implant technology for the benefit of our customers and patients worldwide.”

Founded at the University of Alabama at Birmingham Office for the Advancement of Developing Industries, BioHorizons has expanded its footprint over the past three decades. Today, the Company has offices in the U.S., Canada, Chile, Mexico, UK, Spain, Portugal, and Italy, and a global distribution center at its Birmingham headquarters, occupying more than 125,000 square feet, plus a 50,000-square foot manufacturing facility in Southern California.

BioHorizons joined Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, through an initial investment by Henry Schein in 2013 followed by a full acquisition in 2018.

To learn more about BioHorizons and its global contributions to dental health, visit www.biohorizons.com.

About BioHorizons Camlog

BioHorizons Camlog is a leading supplier of premium dental implant systems, restorative components, a comprehensive line of biologics products, and digital solutions. It is committed to developing evidence-based and scientifically proven products, as well as continuing education adhering to highest standards.

Headquartered in the U.S. and Europe, BioHorizons Camlog’s geographic positions allow it to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as its entire distribution network in more than 90 countries around the world.

The company is part of Henry Schein Inc., a solutions company for healthcare professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, Henry Schein’s network of trusted advisors provides over 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.

For more information, visit www.biohorizonscamlog.com

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and @HenrySchein on X. 

 

###